HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Herbalife appointment

This article was originally published in The Tan Sheet

Executive Summary

Michael Wisk named chief marketing officer for direct seller, Los Angeles-based firm announced July 21. Newly created position places Wisk in charge of worldwide marketing, including distributors, in 58 countries. Wisk, who most recently was VP-marketing for Nokia Mobile Phones for North and South America, will report to CEO Michael Johnson. Announcement follows recent appointment of former Pharmavite co-founder and CEO Henry Burdick as Herbalife vice chairman (1"The Tan Sheet" June 16, 2003, p.14)...

You may also be interested in...



Herbalife exec

Gregory Probert named chief operating officer, with "overall responsibility" for the supplement marketer's business operations in 58 markets around the world, Herbalife says. He joins Herbalife from DMX Music, where he was president and chief executive officer. He also formerly served as exec VP-COO for Disney's Buena Vista Home Entertainment business. Probert replaces Brian Kane, who is relocating to the UK to take over as president of Herbalife Europe. Probert's appointment follows that of former Nokia Mobile Phones VP Michael Wisk as Herbalife's chief marketing officer (1"The Tan Sheet" July 28, 2003, In Brief)...

Herbalife Niteworks For Vascular Support Based On Nitric Oxide Research

Herbalife will unveil its Niteworks dietary supplement powder mix - which contains a proprietary blend of L-arginine and L-citrulline for supporting vascular and circulatory health - at a June 17 event in New York

US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising

US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS129481

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel